September 10, 2025
A Wenger Plattner team led by Oliver Künzler has successfully advised the lead investor in the CHF 56m Series C Round of CUTISS AG, a late-stage clinical TechBio at the forefront of tissue therapeutics and regenerative medicine. The further core team consisted of Suzanne Eckert, Counsel, Corporate/M&A, Daniela Fritsch, Senior Associate, Corporate/M&A, Lynn Grob, Associate, Corporate/M&A and Valérie Berger, Associate, Corporate/M&A.
More information can be found here .
Stay up to date and subscribe to our Newsletter.